Heart Attacks in Young Women: Rarer, Realer Than Assumed, and Too Often Delayed

If you think you may be having a heart attack, call emergency services now. Do not drive yourself. Do not wait to see if it improves.

A 38-year-old having a heart attack does not match the script, which is exactly why hers is more likely to be missed. The clinical expectation that MI belongs to older men is so embedded that it produces systematic delays for young women: longer time to ECG, longer time to catheterization laboratory, less aggressive treatment, and worse outcomes, not because the disease is biologically more severe, but because it takes longer for the picture to resolve into the right diagnosis. The VIRGO study documented this in detail across a large prospective cohort. The data are not ambiguous.

The Mechanism

The dominant mechanism of MI in older adults is atherosclerotic plaque rupture: a plaque in a coronary artery becomes unstable, fissures, triggers thrombus, and occludes the vessel. In young women, a different set of mechanisms accounts for a substantial share of events, and those mechanisms require different diagnostic thinking, different imaging interpretation, and in some cases, fundamentally different management.

Spontaneous coronary artery dissection (SCAD). SCAD is a tear in the inner wall of a coronary artery that creates a false lumen compressing true flow to heart muscle. It is not atherosclerosis. SCAD is the leading cause of MI in women under <50, and over 90% of SCAD cases occur in women. It is also the leading cause of MI in pregnancy and the postpartum period. Standard pre-catheterization assumptions built on atherosclerotic disease can misidentify it: SCAD has a different angiographic appearance, different management (conservative where possible, since wire passage can extend the dissection), and a different prognosis from plaque-driven disease.

Understanding SCAD anatomically clarifies why it is treated so differently, and why the treatment that would be correct for an atherosclerotic MI can make SCAD worse. The coronary artery wall has three layers: the intima (innermost), the media (muscular middle layer), and the adventitia (outer layer). In SCAD, a tear develops in the intima, allowing blood to track between the intima and the media and form an intramural hematoma. That hematoma expands within the wall, compresses the true lumen from the outside, and reduces or eliminates flow to the heart muscle supplied by that vessel. The obstruction is not a clot in the lumen from a ruptured plaque; it is the wall itself bulging inward.

On coronary angiography, SCAD can appear as a long smooth narrowing, as a haziness in the vessel, or as the classic double lumen sign where both the true and false channels are visible. It does not look like the discrete filling defect that marks thrombus at a plaque site. Cardiologists who have not seen many SCAD cases can mistake it for atherosclerotic disease or coronary spasm, and the management path that follows each diagnosis differs critically.

Two structural factors are disproportionately present in women with SCAD. The first is fibromuscular dysplasia (FMD), a non-inflammatory arterial disease that causes abnormal cell growth in artery walls and produces characteristic beading or kinking on imaging. Saw et al. (2017, JACC) found FMD in up to 86% of women with SCAD who underwent systematic vascular screening. FMD is itself more common in women, and the structural weakness it creates in arterial walls provides a substrate for dissection. The second factor is the effect of sex hormones on vascular integrity. Estrogen and progesterone influence the composition of the arterial wall, including collagen and elastic fiber content. The peripartum period involves rapid hormonal shifts that may weaken medial structure, which is why SCAD rates are highest in the days immediately after delivery and in the late third trimester. Connective tissue disorders, including Marfan syndrome and Ehlers-Danlos syndrome (hypermobile type), are also found at higher rates in SCAD patients than in the general population.

In a standard STEMI caused by plaque rupture and thrombus, the goal is to open the artery rapidly: anticoagulation, antiplatelet therapy, and wire-guided balloon or stent deployment. In SCAD, several of those steps can cause harm. Passing a wire through the true lumen of a dissected artery risks entering the false lumen, extending the tear, and converting a manageable dissection into a catastrophic one. Stenting in a dissected segment can propagate the intramural hematoma proximally or distally by the radial pressure of stent expansion. For these reasons, the preferred approach in SCAD with preserved flow (TIMI 3) is conservative management: antiplatelet therapy, beta-blockade to reduce hemodynamic shear, and close monitoring rather than immediate intervention. The Canadian SCAD Registry, reported by Hayes et al. (2018, JACC), showed that among women who underwent percutaneous coronary intervention for SCAD, procedural failure occurred in a substantial minority, underscoring why the conservative default exists.

Coronary vasospasm. Coronary artery spasm causing transient vessel occlusion can produce MI without any fixed atherosclerotic lesion. Vasospasm is more common in women than standard teaching conveys, more likely to produce ST changes at rest or at night, and will appear on coronary angiography only if the spasm is captured during the study. Provocative testing, typically with intracoronary acetylcholine or ergonovine, is required to diagnose it reliably. Women who are younger, who smoke, and who present with chest pain at rest without obstructive lesions on angiography represent the classic vasospasm profile, yet this diagnosis is often not pursued if the angiogram is read as “normal” without provocation.

Risk-factor-driven atherosclerosis, appearing early. When atherosclerosis does cause MI in young women, the risk factor profile often includes factors the standard calculator misses: a history of preeclampsia (which substantially elevates long-term cardiovascular risk), autoimmune disease such as systemic lupus erythematosus or rheumatoid arthritis, premature familial hypercholesterolemia identified only by thorough family history, and drug use including stimulants and cocaine. The chronic systemic inflammation associated with autoimmune disease directly promotes plaque development through endothelial injury and immune complex deposition. These pathways do not appear on the standard intake form if the clinician does not ask for them explicitly.

What the Evidence Shows

MI in women under <50 is uncommon in absolute terms but rising in relative burden. Population-level data show that while MI rates in older adults have been declining, rates in younger women have been stable or increasing over the past two decades. The absolute numbers remain lower than in older patients, but the trajectory is moving in the wrong direction, and the mechanisms driving it differ from those in older cohorts.

The VIRGO study (Lichtman et al.), which enrolled patients aged 18-55 with acute MI at 103 hospitals across the United States and Spain, was designed specifically to examine this cohort because prior cardiovascular trial data had largely excluded younger patients. Young women in VIRGO had worse in-hospital and post-discharge outcomes than young men, with higher rates of readmission and lower rates of receiving evidence-based treatments. Women in the study were more likely to present with a broader symptom profile including fatigue, nausea, and jaw or back pain rather than isolated chest pressure. They waited longer before calling for help, waited longer in the emergency department before ECG, and were less likely to be triaged as high acuity on first presentation. The delay was not confined to one point in the system; it was distributed across all steps from symptom onset to catheterization laboratory activation.

Young women with MI are more likely than men to present with symptoms outside the chest: jaw, neck, or upper back pain; profound fatigue beginning days before the acute event; nausea; shortness of breath without prominent chest pressure. Chest pressure or pain still occurs in a majority of women with MI, and when it does it should trigger emergency response regardless of age. The problem is the presentations that get reframed as musculoskeletal, gastrointestinal, anxiety, or viral illness before anyone considers the heart.

Preeclampsia and hypertensive disorders of pregnancy. A history of preeclampsia is not simply a pregnancy complication that resolves at delivery. It is a vascular injury that leaves a lasting signature on cardiovascular risk. The HUNT study (Romundstad et al., 2010, Circulation) found a two-fold increase in cardiovascular mortality in women who had experienced preeclampsia, compared with women whose pregnancies were uncomplicated. The mechanism involves persistent endothelial dysfunction, accelerated subclinical atherosclerosis, and a higher burden of hypertension and metabolic dysregulation in the years following the affected pregnancy. A woman in her late thirties or forties who had preeclampsia in her twenties carries meaningfully elevated cardiovascular risk that her physician may never have documented or discussed, particularly if the delivery was in a different health system or the obstetric and primary care records have not been integrated.

Autoimmune and inflammatory disease. Systemic lupus erythematosus (SLE) accelerates atherosclerosis at a rate that has no parallel in the general population. Women aged 35 to 44 with SLE have been found to have cardiovascular event rates approximately 50-fold higher than age-matched women without the disease. The mechanism is multifactorial: chronic systemic inflammation directly promotes plaque development, immune complex deposition injures the vascular endothelium, and some medications used to treat SLE, including long-term corticosteroids, carry their own cardiovascular burden. Rheumatoid arthritis confers a smaller but clinically significant increase in cardiovascular risk through a similar pathway of chronic inflammation rather than traditional lipid-driven atherosclerosis. Women with these conditions are often managed exclusively by rheumatologists, with cardiovascular risk assessment falling between specialties and never receiving dedicated attention.

Migraine with aura. Migraine is roughly three times more common in women than in men, and the subtype with aura carries specific cardiovascular implications beyond headache. Kurth et al. (2006, JAMA) found a 1.7-fold increased risk of cardiovascular events specifically in women with migraine with aura, an association not seen in women with migraine without aura and not replicated with the same magnitude in men. The proposed mechanisms include cortical spreading depression affecting vascular reactivity, platelet activation during aura episodes, and endothelial dysfunction. This is not a reason to alter migraine treatment, but it is a reason to include migraine-with-aura in cardiovascular risk conversations for young women, particularly those who also smoke or use estrogen-containing oral contraceptives, both of which compound the aura-associated risk into a meaningful absolute hazard.

Family history through female relatives. The standard practice of asking about heart attack history in fathers and brothers captures only part of the hereditary signal. Women with mothers, sisters, or aunts who had premature MI (before age 65 in a female relative) carry elevated risk that is often never elicited because the clinical question is framed around male relatives. Premature familial hypercholesterolemia may present in young women whose fathers had normal cholesterol, transmitted through maternal lines that were never identified because female relatives were not screened aggressively.

Depression and anxiety. Depression in women under <50 is associated with independent cardiovascular risk beyond what is explained by shared lifestyle factors. The mechanism likely involves autonomic dysfunction, heightened inflammatory activity, and alterations in platelet function. This does not mean that treating depression prevents MI, but it means that a young woman presenting with chest symptoms and a concurrent mental health history should not have the cardiac evaluation short-circuited because anxiety seems like a sufficient explanation for her presentation. In the VIRGO study, women with MI were more likely than men to have been previously diagnosed with depression, and those with depression had worse recovery trajectories regardless of the cardiac mechanism.

What to Do This Week

1. Know that chest pressure, jaw pain, upper back pain, unusual fatigue, or nausea that feels cardiac should prompt emergency services, not a wait-and-see approach, regardless of your age. Young women with MI routinely wait longer before calling for help than their male counterparts, and every additional minute of delay in an occlusive event costs myocardium. The symptom threshold for calling 911 in your thirties is the same as it is in your sixties.

2. If you are a young woman who has had unexplained chest symptoms, ask specifically whether SCAD and vasospasm have been considered as diagnoses, not only plaque-based coronary artery disease. These conditions require different imaging protocols and, in the case of vasospasm, provocative testing that will not be performed unless the clinician is looking for it. A normal standard angiogram does not exclude vasospasm if provocation testing was not done.

3. Ensure your cardiovascular risk assessment includes your full pregnancy history (including any complications such as preeclampsia or gestational hypertension), your autoimmune disease history, and your family cardiac history through female relatives on both sides, not only through fathers and brothers. If your physician uses a standard calculator without asking about these factors, supply the information directly. It changes your risk category.

4. If you had an MI diagnosed as SCAD, connect with a SCAD registry or specialty center: the recurrence rate is real (approximately 14% at five years in the Canadian SCAD Registry, with the highest risk in the first 30 days), the management after a SCAD event differs from standard post-MI protocols, and post-SCAD psychological support is a legitimate and documented clinical need, not a secondary concern. Asking for a referral to cardiac rehabilitation that includes psychological support is appropriate and warranted.

5. If you had an unexplained cardiac event during pregnancy or in the postpartum period, ask specifically whether SCAD was considered and whether it was ruled out by imaging rather than assumed absent. A reassuring angiogram in the early postpartum period warrants repeat imaging at four to six weeks if the initial presentation was suspicious, because the intramural hematoma can heal and be absent on delayed imaging even when it caused the event. Post-MI management during and after pregnancy requires a care team that includes a cardiologist with experience in pregnancy-associated cardiac events, not a standard post-MI pathway designed for a different patient population entirely.

MI in young women is uncommon enough to be surprising and common enough that assuming it will not happen is dangerous. The mechanisms differ from older populations, the symptom presentation differs from the standard teaching used to train most clinicians and most patients, and the healthcare system is not currently built to recognize this patient efficiently. The VIRGO data show that every step of the process, from the moment a woman notices her symptoms to the moment she receives definitive treatment, is slower for her than for her male counterpart with the same diagnosis. Understanding this before it matters is one concrete way to shorten that delay.